来源：环球网 技术突破不止于此，团队运用定向固定化技术，将筛选出的噬菌体在纳米酶上"尾巴朝外"精密排布，一 旦发现致病菌便能瞬间触发反应，将检测时间大大缩短。他们独创的"鸡尾酒协同配伍技术"结合纸基化 传感阵列，使试纸可同步精准检测6种致病菌，配合智能比色软件，一举实现了从定性识别到定量检测 的飞跃。据介绍，"速测安"致病菌快检试纸，覆盖国标的全部种类病菌，满足食品行业的13个分类菌检 的所有要求。 从实验室的潜心钻研到产业一线的落地应用，这项技术展现出强大的破壁之力。在上海昊岳，扬州冶春 等企业试用表明，出厂检测速度极大提升，为企业极大减少检测费用；在扬州市食药检中心，面对海量 检测任务，实现了应检尽检，保障百姓饮食安全。更让扬州东园集团的预制菜产品因快速可靠的检测保 障，成功贴上"放心标签"。 这支团队在实验室里完成了数百次迭代与优化。他们以误差为砺石，将挫败作阶梯。从一张试纸的精准 狙击，到整个食品检测行业的效能跃升；从一项噬菌体技术的原始创新，到千万级市场的商业验证—— 他们希望用行动在致病菌检测的疆域，镌刻下属于中国青年的食安答案。 在扬州大学实验室的灯光下，一张看似普通的试纸正悄然掀起食品安全检测 ...

Financial Data and Key Metrics Changes - The fourth quarter revenues were $225 million, with core revenue down 2.9% for the quarter, impacted by foreign currency and discontinued products [19] - Gross margin in Q4 was 41.2%, affected by lower volume, elevated inventory write-offs, and production inefficiencies [23][24] - Adjusted net income for Q4 was $11 million, down from $22 million in the prior year quarter, primarily due to lower adjusted EBITDA [26] Business Line Data and Key Metrics Changes - Food Safety segment revenues were $162 million in Q4, down 3% year-over-year, with a core revenue decline of 1.3% [19] - Animal Safety segment revenues were $64 million, including a core revenue decline of 6.7% compared to the prior year quarter [20] - Genomics core revenue declined low single digits in Q4, reflecting a sequential improvement [20] Market Data and Key Metrics Changes - Core revenue growth in Europe was up mid single digits, while Asia Pacific was down mid single digits [21] - Latin America region saw a mid single digit decline on a core basis, with growth in some product lines offset by declines in others [22] - U.S. and Canada region experienced low single digit growth in food safety core revenue [22] Company Strategy and Development Direction - The company is focused on improving internal processes and managing through current market conditions to capitalize on future opportunities [17] - A targeted improvement plan has been released to manage the transition period effectively [17] - The company is prioritizing pathogen detection and has launched new products to enhance its offerings in the food safety market [10][19] Management's Comments on Operating Environment and Future Outlook - Management noted that end market conditions have worsened, particularly in food safety, due to inflation pressures on food producers [4][5] - The expectation is for revenue in fiscal 2026 to be between $820 million and $840 million, reflecting ongoing market challenges [29] - Management anticipates that gross margin will face headwinds from sample collection and tariffs, but expects improvements in the second half of the fiscal year [30] Other Important Information - The company completed the divestiture of its cleaners and disinfectants business, resulting in approximately $115 million in net proceeds [27] - Free cash flow in Q4 was roughly breakeven, with total capital expenditures declining to $16 million [28] - The company has successfully remediated two Sarbanes-Oxley material weaknesses [31] Q&A Session Summary Question: Why is this the right time to put out guidance with a new CEO? - Management indicated that the guidance reflects a business-as-usual approach and is intended to provide clarity on the upcoming year [37][38] Question: How much of a headwind is built for next year regarding tariffs? - Management confirmed that the $10 million tariff impact is the expected headwind for fiscal 2026 [41] Question: How does the company plan to grow above market despite consumer pressures? - Management highlighted regulatory opportunities and increased testing focus as key growth drivers [44][45] Question: What are the expectations for food safety industry growth? - Management expects food safety testing to grow at a lower rate than historical mid-single digits due to current market conditions [53][54] Question: What is the expected impact of divestitures on operating expenses? - Management noted that most costs associated with divested businesses will go directly with those businesses, with minimal stranded costs remaining [59][60]

Group 1 - The National Market Supervision Administration has approved the release of the "Guidelines for the Management of Campus Catering Service Enterprises," which will be implemented on December 1, 2025, marking the first national standard for campus catering services [1] - The guidelines require campus catering service companies to conduct comprehensive testing of bulk food ingredients and provide standardized guidance for recipe and raw material management, processing, preparation, and distribution, creating new market opportunities for the food safety testing industry [1] - EasyBio, a company specializing in rapid testing technology, has developed comprehensive testing solutions covering various stages from feed, breeding, production, processing, circulation, to retail, ensuring food safety from source to end [1] Group 2 - EasyBio has recently launched efficient water quality testing solutions, including rapid testing paper for coliform bacteria and an integrated portable multi-parameter water quality testing system, to ensure water safety [2] - The company is deepening cooperation with local government departments, including establishing a quality safety testing service center for agricultural and livestock products in collaboration with the Ordos Municipal Agricultural and Animal Husbandry Bureau [2] - A partnership is being formed to build the "Ordos Agricultural and Animal Husbandry Bay Area Base," facilitating cross-regional industrial collaboration [2] Group 3 - EasyBio signed a cooperation agreement with Denmark's Chr. Hansen in April, setting a global sales target of €73.0577 million (approximately 601 million RMB) for the period from 2025 to 2029, with 2025 accounting for 42.18% of the company's 2024 revenue [3] - The partnership allows Chr. Hansen to exclusively sell, distribute, and promote EasyBio's products globally, including tests for antibiotic residues in milk and aflatoxin M1 screening [3] - EasyBio is also entering the pet economy sector by introducing infectious disease testing products to pet hospitals, although it clarified that it does not currently involve testing for the chikungunya virus [3]

Core Insights - The article highlights the successful collaboration between Beijing and Tianjin, particularly focusing on the development of the Wuqing District as a hub for industrial transfer and innovation [1][5]. Group 1: Economic Development - In the first quarter of this year, Wuqing District introduced 10 market-oriented projects from Beijing, with a total investment of 4.77 billion yuan [1]. - The food safety testing company, Xinuotong Technology Co., which relocated from Beijing to Wuqing, saw its revenue grow from 2 million yuan to 20 million yuan within a year, achieving a 50% annual growth rate [3][5]. Group 2: Infrastructure and Connectivity - The introduction of three additional train services on the Beijing-Tianjin intercity high-speed rail every Friday enhances connectivity to Wuqing [8][10]. - The ongoing expansion of the Beijing-Tianjin-Tanggu Expressway aims to further improve transportation integration between the two cities [8]. Group 3: Policy Support - The Tianjin government has implemented 16 specific policies to support the high-quality development of the Wuqing Tianjin Industrial New City, focusing on attracting businesses and talent [5][12]. Group 4: Innovation and Collaboration - The Wuqing District is fostering a collaborative innovation ecosystem, attracting new production elements, including advancements in low-altitude economy and smart connected vehicles [8]. - The integration of public services allows for the completion of 453 items from Beijing and 211 items from Tianjin through self-service machines, enhancing administrative efficiency [10][12]. Group 5: Consumer Engagement - The "Florence Town" shopping area in Wuqing has launched a comprehensive consumption platform that has gained popularity among visitors, positioning it as a trendy destination in the Beijing-Tianjin-Hebei region [10][14].

Core Viewpoint - The collaboration between EasyBio and Chr. Hansen marks a significant step in the company's internationalization strategy, with a sales target of €73.06 million (over 600 million RMB) from 2025 to 2029, which is expected to positively impact the company's future performance and market presence [1][2][6]. Group 1: Contract Details - EasyBio has signed a cooperation agreement with Chr. Hansen, setting a total sales target of €73.06 million for the period from 2025 to 2029, with the first year's target accounting for approximately 42.18% of the company's 2024 revenue [1][2]. - The sales targets are structured to grow by more than 10% in the first year and 12% in subsequent years, with annual targets increasing from approximately 95 million RMB in 2025 to nearly 150 million RMB in 2029 [2]. - The contract allows Chr. Hansen exclusive rights to sell and promote EasyBio's products globally, excluding specific countries, covering various testing products related to food safety [2][4]. Group 2: Strategic Importance - The partnership is a major breakthrough in EasyBio's internationalization strategy, which has been a key driver of the company's performance since 2023 [2]. - The collaboration will utilize a dual-brand approach, enhancing EasyBio's market penetration in the global dairy product sector while leveraging Chr. Hansen's brand influence [4]. - EasyBio aims to expand its market reach and product offerings beyond dairy, exploring opportunities in various sectors such as food, agriculture, and pharmaceuticals, supported by Chr. Hansen's and Novonesis's expertise [5]. Group 3: Market Impact - The collaboration is expected to enhance EasyBio's core competitiveness and market influence, contributing to sustainable business growth [6]. - EasyBio's international sales have shown significant growth, with overseas revenue increasing by 15.92% in 2024, reaching approximately 93.33 million RMB, and the proportion of overseas revenue rising from 31.68% in 2023 to 41.62% in 2024 [5].